NO20063920L - Koblingsreaksjoner som er nyttige i fremstillingen av (1H-tetrazol-5-yl)-bifenylderivater - Google Patents

Koblingsreaksjoner som er nyttige i fremstillingen av (1H-tetrazol-5-yl)-bifenylderivater

Info

Publication number
NO20063920L
NO20063920L NO20063920A NO20063920A NO20063920L NO 20063920 L NO20063920 L NO 20063920L NO 20063920 A NO20063920 A NO 20063920A NO 20063920 A NO20063920 A NO 20063920A NO 20063920 L NO20063920 L NO 20063920L
Authority
NO
Norway
Prior art keywords
tetrazol
preparation
coupling reactions
biphenyl derivatives
reactions useful
Prior art date
Application number
NO20063920A
Other languages
English (en)
Inventor
Hans Hirt
Christoph Krell
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20063920L publication Critical patent/NO20063920L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Den foreliggende oppfinnelsen vedrører en prosess for produksjonen av intermediater som kan anvendes for produksjonen av ARBer også kalt angiotension II reseptor-antagonister eller AT1 reseptorantagonister) som omfatter som et felles strukturelt trekk en (IH-etrazol-5-yl)-bifenylring.
NO20063920A 2004-02-02 2006-09-01 Koblingsreaksjoner som er nyttige i fremstillingen av (1H-tetrazol-5-yl)-bifenylderivater NO20063920L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0402262.0A GB0402262D0 (en) 2004-02-02 2004-02-02 Process for the manufacture of organic compounds
PCT/EP2005/000978 WO2005075462A1 (en) 2004-02-02 2005-02-01 Coupling reactions useful in the preparation of (1h-tetrazol-5-yl)-biphenyl derivatives

Publications (1)

Publication Number Publication Date
NO20063920L true NO20063920L (no) 2006-10-30

Family

ID=31985494

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063920A NO20063920L (no) 2004-02-02 2006-09-01 Koblingsreaksjoner som er nyttige i fremstillingen av (1H-tetrazol-5-yl)-bifenylderivater

Country Status (19)

Country Link
US (2) US7700784B2 (no)
EP (2) EP1716140A1 (no)
JP (1) JP2007519684A (no)
KR (1) KR20060128993A (no)
CN (1) CN100528868C (no)
AU (1) AU2005211500B2 (no)
BR (1) BRPI0507352A (no)
CA (1) CA2553246A1 (no)
CO (1) CO5700717A2 (no)
EC (1) ECSP066727A (no)
GB (1) GB0402262D0 (no)
IL (2) IL176904A0 (no)
MA (1) MA28427B1 (no)
NO (1) NO20063920L (no)
NZ (1) NZ548690A (no)
RU (2) RU2426728C2 (no)
TN (1) TNSN06238A1 (no)
WO (1) WO2005075462A1 (no)
ZA (1) ZA200605462B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0222056D0 (en) * 2002-09-23 2002-10-30 Novartis Ag Process for the manufacture of organic compounds
JP5023720B2 (ja) * 2006-08-04 2012-09-12 東ソー株式会社 ハロゲン化ビフェニル類の製造方法
FI3067043T3 (fi) * 2007-11-06 2023-03-18 Novartis Ag Angiotensiinireseptoriantagonistin/-salpaajan (arb) ja neutraalin endopeptidaasin (nep) estäjän superrakenteisiin perustuvia farmaseuttisia koostumuksia
PE20091364A1 (es) 2008-01-17 2009-10-13 Novartis Ag Proceso para la preparacion de inhibidores de nep
JP5203144B2 (ja) * 2008-11-07 2013-06-05 東ソー株式会社 スチレン類の製造方法
JP5261140B2 (ja) * 2008-11-07 2013-08-14 東ソー株式会社 ビニル芳香族化合物の製造方法
KR101476937B1 (ko) 2010-08-23 2014-12-24 노파르티스 아게 Ｎｅｐ 억제제의 제조를 위한 중간체의 제조 방법
PL2610248T3 (pl) * 2010-08-27 2016-12-30 Sposób wytwarzania podstawionych fenylem pochodnych heterocyklicznych metodą sprzęgania z użyciem związku palladu
CN103467341B (zh) * 2013-08-29 2015-02-25 河南师范大学 一种沙坦联苯的制备方法
CN104987327A (zh) * 2015-07-13 2015-10-21 朱绍清 一种四唑类衍生物的催化合成方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (en) 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US4874867A (en) * 1987-05-22 1989-10-17 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
DE69034103T2 (de) 1989-06-14 2004-07-15 Smithkline Beecham Corp. Imidazoalkensäure
PH30484A (en) 1990-02-19 1997-05-28 Ciba Geigy Acy compounds pharmaceutical composition containing said compound and method of use thereof
GB9005354D0 (en) * 1990-03-09 1990-05-02 Glaxo Group Ltd Chemical compounds
NZ237476A (en) 1990-03-20 1994-01-26 Sanofi Sa N-substituted heterocyclic compounds and pharmaceutical compositions.
US5196444A (en) 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
CA2229000C (en) 1991-02-21 2002-04-09 Sankyo Company, Limited 1-biphenylimidazole derivatives, their preparation and their therapeutic use
TW226375B (no) 1991-10-24 1994-07-11 American Home Prod
US5206374A (en) * 1991-11-18 1993-04-27 E. I. Du Pont De Nemours And Company Process for preparing tetrazolylphenylboronic acid intermediates
US5310928A (en) * 1991-11-18 1994-05-10 E. I. Du Pont De Nemours And Company Process for preparing biphenyltetrazole compounds
EP0550313A1 (fr) * 1991-12-30 1993-07-07 Synthelabo Nouveaux dérivés de 2-(tétrazol-5-yl)-(1,1'-biphényle), leur préparation et leur utilisation comme intermédiaires de synthèse
FR2688503B1 (fr) 1992-03-16 1994-05-06 Synthelabo Procede de preparation de derives de 2-(tetrazol-5-yl)-[1,1'-biphenyle].
US5468867A (en) * 1994-05-27 1995-11-21 Syntex (U.S.A.) Inc. Process for preparing1-butyl-2-[2'-(2H-tetrazol-5-yl)biphenyl-4-ylmethyl1-1H-indole-3-carboxylic acid
JP4108744B2 (ja) 1994-10-27 2008-06-25 ノバルティス アクチェンゲゼルシャフト テトラゾールの製法
JP3763869B2 (ja) * 1994-12-26 2006-04-05 東ソー・ファインケム株式会社 ビフェニル化合物の製造方法
US5922898A (en) * 1997-04-08 1999-07-13 Catalytica Pharmaceuticals, Inc. Process for preparing biaryl compounds
DE10057679A1 (de) * 2000-11-21 2002-05-29 Forschungszentrum Juelich Gmbh Brennstoffzellenstapel mit Kreislaufführung
BR0313000A (pt) * 2002-07-19 2005-07-12 Memory Pharm Corp Compostos, composição farmacêutica e método para efetuar a inibição da enzima pde4, realçar a cognição e/ou tratar a psicose em um paciente
GB0222056D0 (en) * 2002-09-23 2002-10-30 Novartis Ag Process for the manufacture of organic compounds
CA2640585A1 (en) * 2003-02-05 2004-08-26 Teva Pharmaceutical Industries Ltd. Synthesis of 2-butyl-3-(2'-(1-trityl-1h-tetrazol-5-yl)biphenyl-4-yl)-1,3-diazaspirol{4,4}-non-ene-4-one
PT2272868E (pt) 2003-06-05 2015-07-07 Genentech Inc Terapêutica de combinação para distúrbios de células b

Also Published As

Publication number Publication date
CN1914197A (zh) 2007-02-14
CN100528868C (zh) 2009-08-19
US7700784B2 (en) 2010-04-20
ZA200605462B (en) 2009-06-24
CO5700717A2 (es) 2006-11-30
EP2246348A1 (en) 2010-11-03
CA2553246A1 (en) 2005-08-18
GB0402262D0 (en) 2004-03-10
EP1716140A1 (en) 2006-11-02
JP2007519684A (ja) 2007-07-19
KR20060128993A (ko) 2006-12-14
NZ548690A (en) 2009-08-28
BRPI0507352A (pt) 2007-07-03
IL176904A0 (en) 2006-12-10
US20100152458A1 (en) 2010-06-17
RU2010136996A (ru) 2012-03-20
TNSN06238A1 (en) 2007-12-03
US20070129413A1 (en) 2007-06-07
AU2005211500B2 (en) 2009-04-02
IL208409A0 (en) 2011-08-01
RU2426728C2 (ru) 2011-08-20
AU2005211500A1 (en) 2005-08-18
RU2006131460A (ru) 2008-03-10
MA28427B1 (fr) 2007-02-01
ECSP066727A (es) 2006-10-31
WO2005075462A1 (en) 2005-08-18

Similar Documents

Publication Publication Date Title
NO20063920L (no) Koblingsreaksjoner som er nyttige i fremstillingen av (1H-tetrazol-5-yl)-bifenylderivater
NO20083909L (no) Bisykliske benzimidazolforbindelser, og deres anvendelse som metabotropiske glutamatreseptorforsterkere
DE602006013493D1 (de) Oxadiazolylpyrazolopyrimidine als mglur2-antagonisten
ECSP099044A (es) Compuestos de pirimido fusionados
ECSP055910A (es) Nuevos acidos carboxilicos y sus esteres, medicamentos que contienen estos compuestos y procedimientos para su preparacion
BRPI0508704A (pt) métodos para a preparação de um composto e para a preparação de calcipotriol ou monoidrato de calcipotriol, composto, e, usos de um composto e de éster dietìlico do ácido (2-ciclopropil-2-oxoetil) fosfÈnico
AR054369A1 (es) Compuestos de imidazol condensado y su uso como inhibidores de aldosterona sintasa
EA200970247A1 (ru) Способ получения оптического активного n-защищенного 3-аминопирролидина или оптически активного n-защищенного 3-аминопиперидина и соответствующих кетонов путем оптического разделения рацемических смесей аминов с использованием бактериальной омега-трансаминазы
ECSP088824A (es) Prolinamidas sustituidas, su preparación y su uso como medicamentos
UY30444A1 (es) Derivados de pirimidina, procesos para su preparacinn, composiciones farmaccuticos y usos de los mismos.
SV2011003903A (es) Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa iv para el tratamiento o prevencion de diabetes
CO6280399A2 (es) Peptidil nitrilos y uso de los mismos como inhibidores de peptidil peptidasa i
DOP2011000176A (es) Compuestos organicos
BRPI0508622A (pt) compostos de bifenil úteis como antagonistas do receptor muscarìnico
MY159059A (en) 2-amino-4-arylthiazole compounds as trpa1 antagonists
BRPI0511933B8 (pt) derivados de quinazolinona, seu uso e seu processo de preparação, e composição farmacêutica
TW200714587A (en) Biphenyl compounds useful as muscarinic receptor antagonists
TW200637827A (en) Processes for preparing substituted phenylpyrazole ureas
NI200800227A (es) Acidos 1,3-dioxano carboxilicos
EA200702589A1 (ru) 2,6-хинолинильные производные, способы их получения и их применение
MY154962A (en) Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a seratonin receptor
CY1108880T1 (el) Παραγωγα καρβοξαμιδιου ως ανταγωνιστες μουσκαρινικου υποδοχεα
AR054508A1 (es) Compuesto de bencilpiperazina, su uso para preparar un medicamento, procedimientos para la preparacion de dicho compuesto y de compuestos intermediarios, dichos compuestos intermediarios, composicion farmaceutica que lo comprende y procedimiento para prepararla
MX2010003849A (es) Antagonistas de cgrp.
MX339840B (es) Moduladores de los receptores de 5-ht y metodos de uso de los mismos.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application